These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2851632)

  • 1. Effect of delta 9-tetrahydrocannabinol on intraocular pressure after removal of autonomic input.
    Colasanti BK; Powell SR
    J Ocul Pharmacol; 1985; 1(1):47-57. PubMed ID: 2851632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol.
    Colasanti BK
    J Ocul Pharmacol; 1990; 6(4):259-69. PubMed ID: 1965836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic drug effects after chronic lowering of ocular cholinergic input. II. Intraocular pressure responses.
    Colasanti BK; Wilkinson A
    J Ocul Pharmacol; 1988; 4(3):221-30. PubMed ID: 3198984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular pressure, ocular toxicity and neurotoxicity in response to 11-hydroxy-delta 9-tetrahydrocannabinol and 1-nantradol.
    Colasanti BK
    J Ocul Pharmacol; 1985; 1(2):123-35. PubMed ID: 2851633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta 9-tetrahydrocannabinol or cannabichromene.
    Colasanti BK; Powell SR; Craig CR
    Exp Eye Res; 1984 Jan; 38(1):63-71. PubMed ID: 6323206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic drug effects after chronic lowering of ocular cholinergic input. I. Pupillary responses.
    Colasanti BK
    J Ocul Pharmacol; 1987; 3(1):23-9. PubMed ID: 3503907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.
    Colasanti BK; Brown RE; Craig CR
    Gen Pharmacol; 1984; 15(6):479-84. PubMed ID: 6098513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of delta 9-tetrahydrocannabinol on intraocular pressure in the anaesthetized cat.
    Innemee HC; Hermans AJ; van Zwieten PA
    Doc Ophthalmol; 1980 Apr; 48(2):235-41. PubMed ID: 6249559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior cervical ganglionectomy in monkeys: aqueous humor dynamics and their responses to drugs.
    Gabelt BT; Robinson JC; Gange SJ; Kaufman PL
    Exp Eye Res; 1995 May; 60(5):575-84. PubMed ID: 7615023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of ocular tetrahydrocannabinol effects by adrenergic nervous system.
    Green K; Kim K
    Exp Eye Res; 1976 Oct; 23(4):443-8. PubMed ID: 185078
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction by indomethacin of the degeneration increase in outflow facility after superior cervical ganglionectomy in the rabbit.
    Colasanti BK; Barany EH
    Invest Ophthalmol Vis Sci; 1978 Aug; 17(8):802-5. PubMed ID: 681137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does B-HT 920 lower intraocular pressure in cats by interacting with alpha 2- and/or DA2 adrenoceptors?
    Potter DE; Burke JA
    J Ocul Pharmacol; 1985; 1(1):29-45. PubMed ID: 2906078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural control of intraocular pressure.
    Bergmanson JP
    Am J Optom Physiol Opt; 1982 Jan; 59(1):94-8. PubMed ID: 6798876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic control of the eye.
    McDougal DH; Gamlin PD
    Compr Physiol; 2015 Jan; 5(1):439-73. PubMed ID: 25589275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes.
    Jay WM; Green K
    Arch Ophthalmol; 1983 Apr; 101(4):591-3. PubMed ID: 6301412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective beta 1- and beta 2-adrenoreceptor agonists and antagonists on intraocular pressure in the cat.
    Colasanti BK; Trotter RR
    Invest Ophthalmol Vis Sci; 1981 Jan; 20(1):69-76. PubMed ID: 6108938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility.
    Kiland JA; Gabelt BT; Kaufman PL
    Exp Eye Res; 2004 Mar; 78(3):639-51. PubMed ID: 15106944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man.
    Green K; Roth M
    Arch Ophthalmol; 1982 Feb; 100(2):265-7. PubMed ID: 6279061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid.
    Beilin M; Neumann R; Belkin M; Green K; Bar-Ilan A
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):217-30. PubMed ID: 10872919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of adrenergic antagonists with prostaglandin E2 and tetrahydrocannabinol in the eye.
    Green K; Kim K
    Invest Ophthalmol; 1976 Feb; 15(2):102-11. PubMed ID: 1356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.